Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) shares are surging Friday morning after the company announced fresh financing tied to a private placement and warrant exercise, helping refocus attention on its near-term funding runway. Here’s what investors need to know.
- Scinai Immunotherapeutics stock is showing downward pressure. What’s the outlook for SCNI shares?
What Is Scinai’s $2.61 Million Financing Catalyst?
Scinai announced about $2.61 million in gross proceeds from a private placement financing plus a warrant inducement, with closing expected on or about April 27, 2026, subject to customary conditions.
The warrant inducement covers immediate exercise of up to 229,310 ADSs at 48 cents per ADS, paired with new unregistered warrants for up to 458,621 ADSs at 55 cents per ADS that expire five years from issuance.
The company said it plans to use net proceeds (alongside existing cash) to expand its CDMO platform, advance customer programs, and keep selectively investing in its immunotherapy pipeline.
SCNI Stock: Critical Levels To Watch
Scinai is trying to stabilize off its April swing low while still sitting far below its longer-term trend, which keeps the bigger-picture chart fragile. The stock is trading 43.7% above its 20-day simple moving average (SMA) and 3.6% above its 100-day SMA, which leans toward a short-term rebound that's only starting to test intermediate trend pressure.
The relative strength index (RSI), a momentum gauge, is 25.74, which is in oversold territory and lines up with the oversold signal that appeared in April. RSI at 25.74 reflects heavy recent selling pressure, even if bounces can show up quickly from these levels.
The 12-month return is -65.70%, which is consistent with a longer-term downtrend that hasn't been repaired yet. That longer-term damage also shows up in the moving-average structure, with the 50-day SMA still below the 200-day SMA (a bearish long-term alignment) and price still below the 200-day SMA.
- Key Resistance: $1.00 — a round-number area that often caps early rebound attempts
- Key Support: 50 cents — near the lower end of the recent trading zone
SCNI Stock Price Activity On Friday
SCNI Stock Price Activity: Scinai Immunotherapeutics shares are trading higher by 92.11% to 87 cents at the time of publication on Friday, according to Benzinga Pro data.
Image: Adobe Stock Images
Login to comment